Predictive biomarkers for molecular pathology in lung cancer

被引：6
|
作者：
Pisapia, Pasquale [1 ]
Pepe, Francesco [1 ]
Troncone, Giancarlo [1 ]
Malapelle, Umberto [1 ]
机构：
[1] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
来源：
BIOMARKERS IN MEDICINE | 2020年 / 14卷 / 04期
关键词：
ALK; EGFR; liquid biopsy; molecular oncology; molecular pathology; NGS; novel biomarkers; NSCLC; PD-L1; ROS1; DABRAFENIB PLUS TRAMETINIB; OPEN-LABEL; TESTING GUIDELINE; CHEMOTHERAPY; CRIZOTINIB; INHIBITORS; MUTATIONS; PHASE-2; IMMUNOHISTOCHEMISTRY; ASSOCIATION;
D O I：
10.2217/bmm-2019-0490
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：253 / 256
页数：4
相关论文
共 50 条
  • [41] Targeting molecular alterations in non-small-cell lung cancer: what's next?
    Lopez-Castro, Rafael
    Garcia-Pena, Tania
    Mielgo-Rubio, Xabier
    Riudavets, Mariona
    Teixido, Cristina
    Vilarino, Noelia
    Counago, Felipe
    Mezquita, Laura
    PERSONALIZED MEDICINE, 2022, : 341 - 359
  • [42] Driver mutations as predictive biomarkers in lung cancer
    Nicolas Girard
    Current Respiratory Care Reports, 2012, 1 (1): : 21 - 29
  • [43] Pathology and molecular biology of lung cancer
    Wiethege, T
    Junker, K
    Johnen, G
    Krismann, M
    Müller, KM
    PATHOLOGE, 2000, 21 (06): : 404 - 423
  • [44] Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia
    Loong, Herbert H.
    Raymond, Victoria M.
    Shiotsu, Yukimasa
    Chua, Daniel T. T.
    Teo, Peter M. L.
    Yung, Tony
    Skrzypczak, Stan
    Lanman, Richard B.
    Mok, Tony S. K.
    CLINICAL LUNG CANCER, 2018, 19 (05) : E601 - E608
  • [45] Recommendations of the austrian working group on lung pathology and oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
    Popper H.H.
    Gruber-Moesenbacher U.
    Müllauer L.
    Hutarew G.
    Vesely M.
    Pirker R.
    Hilbe W.
    Ploner F.
    Setinek U.
    Hulla W.
    Maier H.
    Sterlacci W.
    Kirchbacher K.
    Kolb R.
    Hochmair M.
    Webersinke G.
    Stacher E.
    Grabher P.
    Hernler T.
    memo - Magazine of European Medical Oncology, 2013, 6 (2) : 83 - 91
  • [46] Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer
    Thakur, Manish K.
    Gadgeel, Shirish M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 760 - 770
  • [47] Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer
    Prelaj, Arsela
    Tay, Rebecca
    Ferrara, Roberto
    Chaput, Nathalie
    Besse, Benjamin
    Califano, Raffaele
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 144 - 159
  • [48] Pathology and molecular pathology of lung tumours
    Kuester, D.
    Krueger, S.
    PNEUMOLOGE, 2011, 8 (05): : 333 - 337
  • [49] Prognostic and predictive molecular biomarkers in colorectal cancer
    Zhang, Jianzhi
    Zhu, Hao
    Liu, Wentao
    Miao, Ji
    Mao, Yonghuan
    Li, Qiang
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [50] The 2020 update of the recommendations of the Austrian working group on lung pathology and oncology for the diagnostic workup of non-small cell lung cancer with focus on predictive biomarkers
    Popper, Helmut H.
    Gruber-Moesenbacher, Ulrike
    Pall, Georg
    Muellauer, Leonhard
    Hochmair, Maximilian
    Krenbek, Dagmar
    Brcic, Luka
    Schmitz, Katja
    Lamprecht, Bernd
    Eckmayr, Josef
    Hilbe, Wolfgang
    Hutarew, Georg
    Errhalt, Peter
    Kolb, Rainer
    Pirker, Robert
    Setinek, Ulrike
    Webersinke, Gerald
    Absenger, Gudrun
    Hernler, Tamara
    Rauter, Markus
    Wasicky, Richard
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 11 - 26
12345